[Effect of angiotrophin in the treatment of peripheral arteriosclerosis obliterans].
D001162:Arteriosclerosis Obliterans / Q000628:therapy*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007610:Kallikreins; D010184:Pancreatic Extracts; D019789:Tetraethylammonium / Q000627:therapeutic use*; D013919:Thromboangiitis Obliterans / Q000628:therapy*
D007093:Imidazoles; D010184:Pancreatic Extracts; C033969:angiotrofin; D019789:Tetraethylammonium; D007610:Kallikreins
ARTERIOSCLEROSIS OBLITERANS/therapy; IMIDAZOLES/therapeutic use; TETRAETHYLAMMONIUM/therapeutic use; THROMBOANGIITIS OBLITERANS/therapy
L'azione dell'angiotrofina nel trattamento delle arteriopatie obliteranti periferiche.